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Cell proliferation and neuroinflammation in the adult
hypothalamus may contribute to the pathogenesis of
obesity. We tested whether the intertwining of these
two processes plays a role in the metabolic changes
caused by 3 weeks of a high–saturated fat diet
(HFD) consumption. Compared with chow-fed mice,
HFD-fed mice had a rapid increase in body weight
and fat mass and specifically showed an increased
number of microglia in the arcuate nucleus (ARC) of
the hypothalamus. Microglia expansion required the
adequate presence of fats and carbohydrates in
the diet because feeding mice a very high-fat, very
low-carbohydrate diet did not affect cell prolifera-
tion. Blocking HFD-induced cell proliferation by central
delivery of the antimitotic drug arabinofuranosyl cytidine
(AraC) blunted food intake, body weight gain, and adi-
posity. AraC treatment completely prevented the in-
crease in number of activated microglia in the ARC,
the expression of the proinflammatory cytokine tumor
necrosis factor-a in microglia, and the recruitment of
the nuclear factor-kB pathway while restoring hypo-
thalamic leptin sensitivity. Central blockade of cell
proliferation also normalized circulating levels of the
cytokines leptin and interleukin 1b and decreased
peritoneal proinflammatory CD86 immunoreactive
macrophage number. These findings suggest that inhibi-
tion of diet-dependent microglia expansion hinders body
weight gain while preventing central and peripheral in-
flammatory responses due to caloric overload.
Consumption of a high saturated fat diet favors metabolic
disorders by causing inflammation in peripheral organs
(1–3). High-fat diet (HFD)–induced peripheral inflamma-
tion is associated with inflammation in brain areas such as
the hippocampus and the hypothalamus (4–8). In particu-
lar, inflammation in the mediobasal hypothalamus, includ-
ing the arcuate nucleus (ARC), happens rapidly, before
obesity is established (9). Within the ARC, agouti-related
protein (AgRP)– and proopiomelanocortin (POMC)–producing
neurons sense and integrate nutrient and hormonal signals to
guarantee energy homeostasis (10,11). Hypothalamic inflam-
mation causes changes in ARC neurons and, in turn, is
responsible for diet-induced obesity (9,12,13) and insulin
resistance in peripheral organs (14). Studies have shown
that activation of the inflammatory nuclear factor-kB
(NF-kB) pathway and recruitment of proinflammatory micro-
glia in the hypothalamus lead to obesity (9,12,15,16). HFD
intake can also induce cell proliferation and eventually
neurogenesis in the adult hypothalamus, which in turn
modifies the neural circuitry regulating energy balance
(17).
We hypothesized that cell proliferation plays a key role
in the central inflammatory response to HFD and in-
vestigated whether modulation of cell proliferation affects
adaptive behavioral and metabolic changes related to caloric
overload. Thus, mice were fed a chow diet or switched to a
diet high in saturated fat. To control for the impact of fat
and carbohydrate content on cell proliferation, chow-fed
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mice also were switched to a very high-fat, very low-
carbohydrate diet (VHFD). Simultaneously, we blocked
cell proliferation by centrally delivering the antimitotic
drug arabinofuranosyl cytidine (AraC) and evaluated
changes in energy balance, microglia activity, and in-
flammation. These studies revealed that HFD feeding
specifically induces hypothalamic microglia expansion and
that inhibition of HFD-induced cell genesis blunts food
intake and adiposity while preventing hypothalamic and
peripheral inflammation.
RESEARCH DESIGN AND METHODS
Animal Experimental Procedure
Experiments were performed according to European
Union recommendations (2010/63/EU) after approval
from the French Ministry of Agriculture and Fisheries
(authorization number 3309004) and the ethics commit-
tee of the University of Bordeaux. Seven-week-old male
C57BL/6J mice (Janvier Labs, Le Genest-Saint-Isles,
France) were individually housed at 22°C with a 12-h
light/dark cycle (lights off at 1:00 P.M.). Animals had
free access to water and chow (Standard Rodent Diet
A03; SAFE, Augy, France) unless stated otherwise (Table
1). Mice were acclimated for 1 week before the start of the
study. One week after intracerebroventricular surgery,
mice were either maintained on chow or switched to an
HFD (D12492; Research Diets, New Brunswick, NJ). Mice
were fed the HFD for up to 3 weeks (Supplementary Fig.
1A). In related studies, mice were fed chow or switched to
a VHFD (D11111601; Research Diets) for 3 weeks. The
VHFD was chosen so that the number of calories from
saturated fat was similar to that of the HFD but with
limited carbohydrates content, the major source of calo-
ries in chow.
Food intake and body weight were recorded daily. Feed
efficiency was calculated as (body weight gained/caloric
intake) 3 100. At the end of the study, mice were either
anesthetized and perfused for neuroanatomical analysis
or killed by cervical dislocation and tissues and blood
collected for molecular and biochemical analysis. The
number of animals is detailed in the figure legends.
Intracerebroventricular Surgery
Eight-week-old mice were anesthetized with ketamine
(100 mg/kg) and xylazine (10 mg/kg) and then implanted with
a cannula into the lateral ventricle (anteroposterior 20.3 mm
from bregma; lateral 21 mm to bregma; dorsoventral
22.5 mm below skull) by using a stereotaxic apparatus
(David Kopf Instruments). The cannula was connected
to an Alzet osmotic minipump (flow rate 0.11 mL/h
for 4 weeks (model 1004; Alzet Charles River) through
120-mm vinyl tubing (inner diameter 0.69 mm) filled
with artificial CSF (aCSF) (Tocris Bioscience). The mini-
pumps were filled with aCSF containing 4.5 mg/mL BrdU
(Sigma) with or without AraC 15 mg/mL (Sigma) and
then primed overnight at 37°C in 0.9% saline.
Body Composition Analysis
Analysis was performed as previously described (18).
Western Blot Analysis
Proteins from hypothalami were extracted and quantified
and Western blots carried out as previously described
(19). Nitrocellulose membranes were incubated over-
night at 4°C with rabbit anti–phospho-STAT3 (p-STAT3)
(Tyr705, 1/4,000; Cell Signaling) or rabbit anti-inhibitor
of kBa (IkBa) (1/1,000; Cell Signaling). After washing,
membranes were incubated with a horseradish peroxidase–
conjugated secondary antibody (goat anti-rabbit 1/2,000;
Cell Signaling). Immunoreactive (IR) bands were revealed by
using enhanced chemiluminescence (ECL Plus; PerkinElmer)
and then exposed to radiographic films (Amersham Hyperfilm
ECL; GE Healthcare Life Sciences). Membranes were stripped
with 2-mercaptoethanol and then reblotted with rabbit anti-
STAT3 (1/4,000; Cell Signaling). Blot quantification was per-
formed with ImageJ software (National Institutes of Health,
Bethesda, MD).
Hormone, Glucose, and Cytokine Measurements in
Plasma
Plasma leptin and insulin were measured using ELISA kits
from Abcam (Paris, France) and Mercodia (Uppsala,
Sweden), respectively. Plasma glucose was measured with
a glucose assay colorimetric kit (Abcam). Measurements
were performed according to manufacturer instructions.
HOMA of insulin resistance index was calculated as follows:
(glucose mmol/L 3 insulin mU/L)/22.5.
Multiplex assays were performed according to manu-
facturer instructions (Bio-Rad) to quantify levels of
plasma interleukin 1b (IL-1b) and tumor necrosis factor-a
(TNF-a) (Milliplex MAP Mouse Cytokine/Chemokine
Magnetic Bead Panel; Merck Millipore, Guyancourt,
Table 1—Characteristics of the diets used in the study
Calories from macronutrients (%)
Type of diet Caloric content (kcal/g) Fat Carbohydrate Protein
Chow (A03; SAFE) 3.2 14 61 25
HFD (D12492; Research Diets) 5.24 60a 20 20
VHFD (D11111601; Research Diets) 6.1 80b 5 16
a40% from saturated fatty acids. b50% from saturated fatty acids.
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France) (5,20). Data were obtained by a Bio-Plex 200
system and analyzed with Bio-Plex Manager software
(Bio-Rad).
Quantitative Real-Time PCR
Hypothalami were homogenized and quantitative real-
time PCR reactions and analyses were performed as pre-
viously described (18). Reference genes were Nono and Sdha.
Primer sequences are listed in Supplementary Table 1.
Isolation of Peritoneal Macrophages
Resident peritoneal macrophages were harvested by
washing the peritoneal cavity with 10 mL of 13 PBS. Cells
were centrifuged at 600g, and the cell pellet was sus-
pended in PBS/BSA 0.1% for flow cytometry analysis.
Flow Cytometry
Cells were washed and incubated for 45 min with the
following antibodies: anti-CD11b-APC, anti-CD45-PerCP
Cy5.5, and anti-CD86-FITC (eBioscience) and anti-CD36-PE
(BioLegend, Saint-Quentin-en-Yvelines, France). Cells were
washed and suspended in PBS/BSA 0.1% for analysis.
Nonspecific, isotype-matched antibodies were used to
assess nonspecific binding. A BD Biosciences LSRFortessa
multicolor flow cytometer was used to determine antigen
expression. For each sample and isotype-matched conju-
gate, 10,000 events were recorded. Data were analyzed
with FlowJo software, and gating for each antibody was
determined on the basis of nonspecific binding of
appropriate negative isotype-stained control.
Tissue Processing and Immunohistochemistry
Animals were anesthetized with 0.1 mL pentobarbital i.p.
and perfused transcardially with cold 0.1 mol/L PBS, pH
7.4, followed by 4% buffered paraformaldehyde. Brains
were collected, postfixed at 4°C overnight, and transferred
into 30% sucrose solution at 4°C. Thirty-micrometer-thick
free-floating coronal sections were cut with a cryostat
(Leica) and stored in cryoprotectant medium (30% ethyl-
ene glycol, 30% glycerol in Krebs PBS) at 220°C until
further processing. Antibodies used are listed in Supple-
mentary Table 2.
Single immunolabelings were performed using similar
procedures. Sections were incubated in 3% H2O2 in 13
PBS before blocking in 5% normal goat serum (Sigma) and
0.3% Triton X-100 in PBS for 1 h. Sections were incubated
overnight with primary antibody at 4°C in blocking buffer.
After washes, sections were incubated with secondary an-
tibody in 1% normal goat serum-PBS for 2 h followed by
1-h incubation in a peroxidase-conjugated avidin/biotin
complex solution (VECTASTAIN Elite ABC System; Vector
Laboratories), and staining was visualized using a DAB
Peroxidase (HRP) Substrate Kit (Vector Laboratories).
Sections were washed in PBS and coverslipped. For
BrdU immunostaining, sections were first incubated in a
3% H2O2 solution and then washed before treatment with
2 N HCl for 30 min at 37°C. Sections were then processed
as described above. For phenotyping BrdU-labeled cells, a
two-step procedure was performed. Sections were first
processed for ionized calcium-binding adapter molecule
1 (Iba1), glial fibrillary acidic protein (GFAP), and neuro-
nal nuclei (NeuN) staining and then for BrdU. Sections
were finally washed and coverslipped with mounting me-
dium (ProLong Gold; Thermo Fisher Scientific).
Quantitative Analysis
For single 3,39-diaminobenzidine immunodetection, digi-
tal images were captured by using a Leica DM5000 micro-
scope. The numerical density of X-IR cells (Nv) or the total
number of cells was estimated from counts made by sys-
tematic random sampling of every 10th section by a blind
observer who used a semiautomatic neuron-tracing sys-
tem (Neurolucida; MBF Bioscience).
The numerical density of Iba1-IR cells or BrdU-IR cells
(number cells/mm3) in the left- and right-side hypothalami
was determined for at least three sections per brain
containing the nucleus of interest. The number of cells
was divided by the sectional volume of the area containing
the ARC (from bregma 21.22 to bregma 22.70 mm), the
paraventricular nucleus (PVN) (from bregma 20.34 to
bregma 21.10 mm), or the ventromedial nucleus (from
bregma 21.06 to bregma 22.00 mm). The same area was
used for the same region investigated among the experi-
mental groups.
The numerical density of Iba1-IR cells (number
cells/mm3) in the hippocampus was evaluated for at least
five sections by using 50 3 50 3 10-mm frames at evenly
spaced x-y intervals of 300 3 300 mm. Nv was calculated




where Q2 is the sum of cells, P is the number of frames, h
is the dissector height, and a(fra) is the area of the count-
ing frame. Cells in sharp focus in the uppermost focal
plane were disregarded (optical dissector principle).
The total number of BrdU-IR cells in the dentate gyrus
was quantified throughout the septotemporal axis accord-
ing to Eq. 2:
N5SQ31=ssf (Eq. 2)
where 1/ssf is the inverse of the section sampling fraction
(10). The dentate gyrus was used as the positive control
area for cell proliferation.
Soma size of Iba1-IR cells was analyzed with ImageJ
software. Images underwent automated thresholding, and
the areas occupied by the somas were obtained by per-
forming the analyze particle function and expressed as
square micrometers per cell. A soma size .65 mm2 was
used as an indicator of activated microglia (21).
The phenotype of BrdU-IR cells was analyzed by using
a confocal microscope with HeNe and Ar lasers (Leica
DM2500 TCS SPE) with a 633 objective (1.4 numerical
aperture) and through the z-axis at 0.6-mm intervals.
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Twenty-nine sections containing the ARC from five animals
were analyzed. Within the ARC, 173 BrdU-IR cells and
1,095 Iba1-IR cells were analyzed. Sections were automat-
ically scored for double labeling with ImageJ software.
Statistical Analysis
Values are reported as mean 6 SEM. Data were analyzed
by unpaired Student t test or by one-way, two-way, or
two-way repeated ANOVA followed by Fisher least signif-
icant difference post hoc analysis. P , 0.05 denotes sta-
tistical significance.
RESULTS
HFD Specifically Induces Cell Proliferation in the ARC
Eight-week-old male chow-fed mice centrally received BrdU
with or without AraC for 4 weeks. After 1 week from the
surgery, animals either continued to eat chow or were
switched to an HFD or a VHFD for 3 weeks (Supplementary
Fig. 1A). After 4 weeks of central BrdU infusion, BrdU-IR
cells were detected in the parenchyma surrounding the third
ventricle and specifically in the ARC of chow-aCSF mice (Fig.
1A and B). Three weeks of HFD consumption doubled the
number of BrdU-IR cells in the ARC (Fig. 1A and B), whereas
it did not affect cell proliferation in the PVN, ventromedial
nucleus, or dentate gyrus (Supplementary Fig. 1B–D). Con-
versely, feeding with a VHFD did not alter cell proliferation
in the ARC (Supplementary Fig. 2A). Infusion of AraC within
the lateral ventricle completely abolished (no BrdU-IR cells
observed) cell proliferation in both the hypothalamus and
the hippocampus, regardless of the diet.
Blockade of Cell Proliferation Blunts HFD-Induced
Weight Gain by Decreasing Food Intake
Three weeks of HFD consumption increased weight,
caloric intake, and fat mass while reducing lean mass
gain (Fig. 1C–F). AraC treatment during HFD blunted the
increase in body weight, caloric intake, and fat mass and
preserved lean mass gain (Fig. 1C–F). The decrease in food
intake accounted for the effect on weight because the feed
efficiency was comparable between HFD-aCSF– and HFD-
AraC–treated animals (Fig. 1G). Conversely, AraC had no
effect in chow-fed (Fig. 1C–G) or VHFD-fed mice (Supple-
mentary Fig. 2B–E). HFD intake altered plasma glucose,
insulin, and HOMA of insulin resistance, which were not
further modified by AraC (Supplementary Fig. 3).
The inhibition of hyperphagia induced by AraC in
HFD-fed mice was particularly evident during the first
week of HFD, when animals typically show an increase in
energy intake, which wanes over time (Supplementary Fig.
4) (9,22). We analyzed changes in neuropeptides known to
regulate this behavior after 1 week of HFD. AraC treatment
in HFD-fed mice significantly suppressed the mRNA ex-
pression of AgRP (Fig. 2A) and tended to do so for neuro-
peptide Y (NPY) (Fig. 2B); both are orexigenic peptides
produced in the ARC. Consistent with previous evidence
(23), short exposure to HFD enhanced the hypothalamic
mRNA levels of the anorectic POMC (Fig. 2C), likely in the
attempt to counterregulate the caloric overload. AraC
completely prevented this effect (Fig. 2C). Expression of
neuropeptides produced outside the ARC, such as the
corticotrophin-releasing hormone (CRH) in the PVN or the
melanin-concentrating hormone (MCH) and prepro-orexin
in the lateral hypothalamus, were not altered by either the
diet or the AraC treatment (Fig. 2D–F). After 1 week of
HFD, cell proliferation tended to increase in the ARC
(BrdU-IR cells 1,558 6 277.8 vs. 2,779 6 829.6/mm3 in
chow-aCSF vs. HFD-aCSF, respectively; t7 = 1.256; P = 0.25;
n = 4–5 mice/group). At this time, AraC had already abol-
ished proliferation (no BrdU-IR cells observed) in the
hypothalamus and hippocampus. Thus, inhibition of cell
genesis affects ARC neuronal responses, which likely par-
ticipate in the hyperphagia observed during HFD exposure.
Blockade of Cell Proliferation Restores Hypothalamic
Leptin Sensitivity and Decreases Peripheral
Inflammation
A characteristic of animals that show changes in fat mass
is that fat mass changes are usually linked to changes in
plasma leptin levels. After 3 weeks of HFD, plasma leptin
levels were significantly reduced in HFD AraC mice
compared with HFD-aCSF–treated animals, and they
were undistinguishable from those observed in chow-fed
mice (Fig. 3A). Conversely, consumption of a VHFD mod-
estly increased plasma leptin levels, which were not al-
tered by AraC (Supplementary Fig. 2F). Therefore, we
evaluated changes in hypothalamic leptin-dependent sig-
naling. AraC fully prevented the typical HFD-induced in-
crease in the expression of SOCS3, the inhibitor of leptin
signaling (Fig. 3B), while partly blunting STAT3 phosphor-
ylation (Fig. 3C), suggesting overall the reestablishment of
normal hypothalamic leptin sensitivity.
Leptin is a proinflammatory cytokine implicated in the
low-grade inflammation observed in diet-induced obesity
(24,25). Therefore, we assessed changes in other proin-
flammatory cytokines and found that AraC treatment
completely prevented the HFD-dependent increase in
plasma IL-1b (Fig. 4A) so that HFD-AraC and chow-
aCSF mice had similar levels of this cytokine. Chow-
AraC–treated animals were not included in this analysis
because they were behaviorally and molecularly indistin-
guishable from chow-aCSF animals (Figs. 1–3). Differently
from IL-1b, no change in circulating TNF-a was observed
in response to either the diet or the treatment (Fig. 4B).
Because macrophages are a main source of cytokines (26),
we evaluated phenotypic changes of macrophages from
the peritoneal cavity, a preferred site for the collection
of naive tissue-resident macrophages (27). Peritoneal
proinflammatory CD86-IR macrophages were reduced in
HFD-AraC compared with HFD-aCSF mice (Fig. 4C), al-
though the pool of anti-inflammatory CD36-IR macro-
phages was unchanged (Fig. 4D).
Blockade of Cell Proliferation Prevents Hypothalamic
Neuroinflammation
Having found that AraC treatment inhibited peripheral
inflammation in HFD-fed mice, we focused on hypothalamic
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inflammation. HFD consumption caused microglia accumu-
lation in the ARC (Fig. 5A and B), with the microglia, labeled
with Iba1, displaying the typical morphology of activated cells
with enlarged soma size (Fig. 5A–C). AraC during HFD de-
creased the number of Iba1-IR cells (Fig. 5A and B) and
blunted the characteristic morphological changes of microglial
activation (Fig. 5C). Of note, the number of ARC Iba1-IR cells
correlated with plasma leptin levels (Pearson r = 0.57; P ,
0.05). Microglia number or morphology was not altered in
the hippocampus, suggesting that microglia activation was
not generalized to the whole brain (Supplementary Fig. 5A
and B). Besides, HFD-aCSF–treated mice displayed a strong
expression of TNF-a in the ARC, highly colocalized with Iba1
(Fig. 5D and E). This HFD-dependent increase in TNF-a was
Figure 1—Inhibition of cell proliferation in the mouse adult hypothalamus hinders HFD-induced body weight gain and adiposity by
decreasing caloric intake. A: Representative staining for BrdU in the ARC of chow- or HFD-fed mice treated or not with AraC. Scale
bar = 15 mm. B: Density of BrdU-IR cells in the ARC (t9 = 2.288; P < 0.05; n = 5–6 mice/group). C–G: Body weight gain [two-way ANOVA:
diet effect F(1,33) = 15.46, P < 0.0005; treatment effect F(1,33) = 0.4085, P = 0.53; interaction F(1,33) = 5.077, P < 0.05; n = 9–10 mice/group],
caloric intake [two-way ANOVA: diet effect F(1,33) = 68.96, P < 0.0005; treatment effect F(1,33) = 5.248, P < 0.05; interaction F(1,33) = 4.146,
P < 0.05; n = 9–10 mice/group], difference in fat mass [two-way ANOVA: diet effect F(1,33) = 84.22, P < 0.0005; treatment effect F(1,33) =
2.867, P = 0.10; interaction F(1,33) = 5.041, P < 0.05; n = 9–10 mice/group], difference in lean mass [two-way ANOVA: diet effect F(1,33) =
9.111, P < 0.005; treatment effect F(1,33) = 0.799, P = 0.377; interaction F(1,33) = 0.471, P = 0.49; n = 9–10 mice/group], and feed efficiency
[two-way ANOVA: diet effect F(1,33) = 0.4492, P = 0.51; treatment effect F(1,33) = 0.1421, P = 0.71; interaction F(1,33) = 1.686, P = 0.2; n = 9–10
mice/group] in chow- and HFD-fed mice treated or not with AraC. *P < 0.05, ***P < 0.0005 vs. chow-aCSF; §§P < 0.005, §§§P < 0.0005
vs. chow-AraC; #P < 0.05, ##P < 0.005 vs. HFD-aCSF; °°P < 0.005, °°°P < 0.0005 diet effect. 3V, third ventricle.
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prevented by AraC treatment (Fig. 5D and E). Accordingly,
hypothalamic protein levels of IkBa, a negative regulator of
NF-kB inhibited by TNF-a (28), were decreased by HFD and
tended to be restored by AraC (Fig. 5F).
We then determined the phenotype of the newly gener-
ated cells in the ARC of HFD-fed mice. Double labeling of
BrdU-IR cells with Iba1 (Fig. 6A–C) revealed strong colocaliza-
tion (436 9% of BrdU-IR cells were labeled Iba1). In contrast,
BrdU-IR cells did not express GFAP (Fig. 6A), a marker of
astrocytes, or NeuN, a marker of mature neurons (Fig. 6A).
Altogether, these results suggest that HFD consumption
causes rapid expansion and proinflammatory activation of
microglia in the ARC and that blockade of this process
prevents both hypothalamic and peripheral inflammation
while blunting excessive caloric intake and body weight gain.
DISCUSSION
Both central and peripheral inflammation contribute to
diet-induced obesity, insulin resistance, and type 2 diabetes
(29). Consumption of an HFD causes inflammation in the
hypothalamus (4,9,12,30); however, the underlying mech-
anisms remain poorly understood.
We demonstrate that exposure for a brief period (up to
3 weeks) to a diet rich in saturated fats induces cell genesis
in the ARC. Stimulation of cell proliferation leads to new
microglia with a proinflammatory phenotype, which is
associated with increased caloric intake, body weight gain,
and peripheral inflammation, all changes that could be
prevented in part or completely by inhibiting cell pro-
liferation through the central delivery of AraC.
HFD specifically increases cell proliferation in the ARC,
but not in other hypothalamic nuclei or well-known cell
proliferative and neurogenic structures, such as the
dentate gyrus of the hippocampus (31). This cell prolifer-
ative response, in turn, results in microglia expansion.
Microglia are known to take up residence in the CNS
during development (32) and can self-renew in the adult
brain (33–35). Differently from other brain areas, the
Figure 2—Blockade of cell proliferation affects hypothalamic neuropeptide expression. A–F: mRNA expression levels of AgRP [two-way
ANOVA: diet effect F(1,16) = 4.63, P< 0.05; treatment effect F(1,16) = 1.877, P = 0.19; interaction F(1,16) = 5.66, P< 0.05; n = 4–6 mice/group],
NPY [two-way ANOVA: diet effect F(1,16) = 5.543, P < 0.05; treatment effect F(1,16) = 1.531, P = 0.23; interaction F(1,16) = 4.011, P = 0.062;
n = 4–6 mice/group], POMC [two-way ANOVA: diet effect F(1,16) = 8.15, P < 0.05; treatment effect F(1,16) = 5.39, P < 0.05; interaction
F(1,16) = 9.75, P < 0.05; n = 4–6 mice/group], CRH [two-way ANOVA: diet effect F(1,16) = 0.24, P = 0.63; treatment effect F(1,16) = 0.001,
P = 0.97; interaction F(1,16) = 0.001, P = 0.97; n = 4–6 mice/group], pre-MCH [two-way ANOVA: diet effect F(1,16) = 0.002, P = 0.96; treatment
effect F(1,16) = 0.32, P = 0.57; interaction F(1,16) = 0.009, P = 0.92; n = 4–6 mice/group], and prepro-orexin [two-way ANOVA: diet effect
F(1,16) = 0.008, P = 0.92; treatment effect F(1,16) = 0.21, P = 0.65; interaction F(1,16) = 0.079, P = 0.78; n = 4–6 mice/group] in the
hypothalamus of mice maintained on chow or HFD for 1 week and treated or not with AraC. *P < 0.05, **P < 0.005 vs. chow-aCSF;
§§P < 0.005 vs. chow-AraC; #P < 0.05, ##P < 0.005 vs. HFD-aCSF; °P < 0.05 diet effect.
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ARC is vascularized by fenestrated vessels that facilitate
the passage of circulating signaling molecules (36). This
anatomical characteristic probably explains why inflam-
matory responses are readily observed in this brain area
compared with other brain structures. This explanation
also holds true for obese humans, where exacerbated
microglia dystrophy is observed in the mediobasal hypo-
thalamus but not in the cortex or amygdala (9,37). Evi-
dence suggests that microglia work in the ARC as a sensor
of saturated fatty acids (38). Such function is particularly
Figure 3—AraC administration restores hypothalamic sensitivity to leptin. A: Plasma leptin levels of chow- and HFD-fed mice treated or not
with AraC [two-way ANOVA: diet effect F(1,29) = 9.19, P < 0.05; treatment effect F(1,29) = 7.17, P < 0.05; interaction F(1,29) = 4.46, P < 0.05;
n = 8–9 mice/group]. B: Hypothalamic mRNA expression levels of SOCS3 in chow- and HFD-fed mice treated or not with AraC [two-way
ANOVA: diet effect F(1,15) = 4.394, P = 0.053; treatment effect F(1,15) = 2.367, P = 0.144; interaction F(1,15) = 8.404, P < 0.05; n = 4–6 per
group]. C: Representative Western blots and quantification of p-STAT3 [two-way ANOVA: diet effect F(1,15) = 5.421, P < 0.05; treatment
effect F(1,15) = 0.588, P = 0.455; interaction F(1,15) = 0.691, P = 0.419; n = 4–5 mice/group] protein expression in the mediobasal hypo-
thalamus of chow- and HFD-fed mice treated or not with AraC. **P < 0.005 vs. chow-aCSF; §P < 0.05, §§§P < 0.0005 vs. chow-AraC;
##P < 0.005 vs. HFD-aCSF; °P < 0.05 diet effect. veh, vehicle.
Figure 4—AraC administration inhibits HFD-induced peripheral inflammation. A and B: Plasma IL-1b [one-way ANOVA: F(2,23) = 3.659, P <
0.05; n = 8–9 mice/group] and plasma TNFa [one-way ANOVA: F(2,24) = 0.2977, P = 0.75; n = 8–10 mice/group] levels in chow-aCSF–, HFD-
aCSF–, and HFD-AraC–treated mice. C and D: FACS analysis of peritoneal proinflammatory CD86-IR (t10 = 2.301, P < 0.05; n = 6
mice/group) and anti-inflammatory CD36-IR (t10 = 0.007, P = 0.9; n = 6 mice/group) macrophages from HFD-fed mice treated or not
with AraC. *P < 0.05 vs. chow-aCSF; #P < 0.05 vs. HFD-aCSF.
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Figure 5—HFD-induced hypothalamic inflammation is blocked by AraC. A: Representative images and higher magnification inset of
microglial cells labeled with Iba1 in the ARC of chow- and HFD-fed mice treated or not with AraC. Scale bar = 15 mm (main panel) and
4 mm (inset). B: Quantification of Iba1 staining in the ARC [two-way ANOVA: diet effect F(1,13) = 3.162, P = 0.09; treatment effect F(1,13) =
28.19, P < 0.0005; interaction F(1,13) = 15.73, P < 0.005; n = 3–5 mice/group]. C: Percentage of Iba1-IR cells in the ARC with soma
size >65 mm2 [two-way ANOVA: diet effect F(1,13) = 13.75, P < 0.005; treatment effect F(1,13) = 3.701, P = 0.076; interaction F(1,13) = 4.674,
P < 0.05; n = 3–5 mice/group]. D: Representative confocal pictures of the double staining against TNF-a (red) and Iba1 (green) in the ARC
of chow- and HFD-fed mice treated or not with AraC. Scale bars = 25 mm. E: Quantification of TNF-a staining in the ARC [two-way ANOVA:
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fitting, considering the ability of ARC neurons to rapidly
sense and integrate nutrient changes to modify behavior
(10). Consequently, different nutrient-related signals
would be expected to differentially affect cell proliferation
in the ARC. This conclusion is supported by our observa-
tion that microglia expansion in the ARC depends on the
type of diet consumed. Indeed, when animals ate a VHFD
with a content of saturated fats comparable to that of the
HFD but with only 5% of calories from carbohydrates,
which are abundant in chow, cell proliferation was indis-
tinguishable from that observed in chow-fed mice. Con-
sumption of saturated fat, therefore, likely increases cell
proliferation only when associated with appropriate in-
take (.5%) of carbohydrates. Besides, inhibition of cell
proliferation in chow did not alter energy balance or
inflammatory responses, implying that this process
becomes relevant only when engaged as a counterregula-
tory mechanism in response to physiologic or environ-
mental changes (39).
The type of diet used and the relatively short exposure
to it could explain why we observed proliferation of
microglia but not of neurons or astrocytes in the ARC.
This point is critical because of conflicting evidence about
the role and nature of hypothalamic cell proliferation. In
fact, some studies have shown that inhibition of hypo-
thalamic cell proliferation decreases body weight (39–41),
which agrees with the current findings, whereas others
describe an increase in body weight (42,43). In particular,
neurogenesis has been found in the ARC (44,45). How-
ever, HFD feeding can suppress neurogenesis (41,46), not
alter the neuronal fate rate (43), or induce (;6% increase)
the generation of new neurons in this area in a sex- and
age-dependent manner (40,41). Moreover, astrogliosis
is present in the ARC of obese animals and humans
(9,13,37) but could be a consequence of signals from ac-
tivated microglia.
Several technical factors such as the route and length of
BrdU administration, the time point of the neuroanatomical
analysis, and the age and sex of the animals studied could
help to explain these seemingly contradictory findings.
Besides, although BrdU labels all proliferating cells, some
of these cells are immature or dying (47).
The current data demonstrate that cell proliferation is
required to observe the HFD-associated inflammatory
response in the ARC because AraC treatment in HFD-fed
mice prevented the increase in hypothalamic microglia
activation and blunted the recruitment of the NF-kB
pathway. Of note, HFD consumption does not alter
microglia functionality because microglia from HFD-fed
animals retain full ability to respond to additional stimuli
(i.e., lipopolysaccharide) and react to changes in their sur-
roundings (7,37). However, microglia activation not only
is the result of the action of specific saturated fatty acids
introduced with the diet but also can be linked to other
nutrient (i.e., related to high-sucrose intake) and hor-
monal signals, for which changes in circulating levels are
observed in conditions other than HFD consumption
(7,16,38,48,49). In particular, increased levels of circulat-
ing leptin and cytokines induce microglia activation
(16,50–54). We observed augmented plasma leptin and
IL-1b levels in HFD-fed mice, which might have activated
existing microglia in the ARC. In support of this interpre-
tation, a positive correlation was found between plasma
leptin and number of ARC Iba1-IR cells. As for IL-1b, its
release from microglia can be stimulated by leptin (52),
and hypothalamic increase in IL-1b signaling due to early
overnutrition is associated with defective melanocortin
signaling, which favors food intake (55).
The current results differ from those of previous
studies where HFD-induced hypothalamic inflammation
was observed in the absence of peripheral inflammation
(7,9). This difference may rely on the techniques used and
signals investigated because we studied circulating levels
of cytokines by immunoassay and looked at peritoneal
macrophage phenotypes by FACS, whereas others have
performed quantitative real-time PCR for inflammatory
markers in peripheral tissues (7,9). Alternatively, diet
might have a direct effect on peripheral immune cells
because monocytes have nutrient-related receptors of
which expression correlates with a range of metabolic
and inflammatory markers (56,57).
Further studies will clarify whether the decreased
peripheral inflammation induced by AraC is due to the
decrease in fat mass observed or whether other mecha-
nisms that directly link central with peripheral inflam-
matory responses might instead be involved. The latter
hypothesis is supported by the observation that although
AraC treatment only partly inhibits fat mass gain in HFD-
fed mice, it completely prevents increases in plasma leptin
and IL-1b levels.
Blockade of cell proliferation during HFD exposure
may also alter microglia-neuron interaction. The typical
increase in caloric intake during the first week of HFD
(9,22) is blunted by AraC treatment. This reduction in
caloric intake is associated with changes in the expression
of neuropeptides produced by ARC neurons. Thaler et al.
(9) found that feeding rats an HFD (the same one we
used) for 1 week increased Iba1 staining and caused
diet effect F(1,17) = 7.098, P < 0.05; treatment effect F(1,17) = 3.99, P = 0.062; interaction F(1,17) = 7.624, P < 0.05; n = 4–7 mice/group]. F:
IkBa protein expression in the mediobasal hypothalamus of chow- and HFD-fed mice treated or not with AraC [two-way ANOVA: diet effect
F(1,15) = 18.58, P < 0.005; treatment effect F(1,15) = 4.389, P = 0.053; interaction F(1,15) = 3.911, P = 0.066; n = 4–5 mice/group]. *P < 0.05,
**P < 0.005 vs. chow-aCSF; §P < 0.05, §§P < 0.005, §§§P < 0.0005 vs. chow-AraC; #P < 0.05, ##P < 0.005, ###P < 0.0005 vs. HFD-
aCSF; °P < 0.05, °°P < 0.005 diet effect. 3V, third ventricle; veh, vehicle.
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neuronal stress as assessed by the increased expression of
the chaperon protein Hsp72 in ARC neurons. Valdearcos
et al. (38) described similar results after 4 weeks of HFD
or even short-term (3 days) administration of saturated
fatty acids by gavage. In the latter study, microglia de-
pletion abolished Hsp72 expression in neurons, suggesting
Figure 6—HFD feeding leads to hypothalamic microglia proliferation. A: Representative confocal images of coimmunodetection of BrdU
(green) with Iba1, GFAP, or NeuN (red). Scale bars = 20 mm. B and C: Representative higher magnification and three-dimensional re-
construction of the colocalized Iba1/BrdU (red/green) staining. Scale bars = 7 mm (B) and 5 mm (C). 3V, third ventricle.
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that neuronal stress is triggered by increased microglia activ-
ity. Neuronal stress in response to HFD is associated with
increased NF-kB signaling (12). Conversely, genetic deletion
of Ikb kinase subunit b (a component of the NF-kB pathway)
in AgRP neurons decreases HFD intake (12). In the current
study, HFD-fed mice had increased hypothalamic expression
of SOCS3, which is a marker of augmented NF-kB activity
(12), and decreased IkBa protein, a negative regulator of
NF-kB (58). These changes were prevented by AraC. Thus,
blockade of cell genesis, by reducing microglia proliferation
and activity, probably blunts neuronal stress responses, result-
ing in changes in neuropeptides known to affect feeding.
Altogether, the evidence we provide linking consump-
tion of a high saturated fat diet with hypothalamic pro-
inflammatory microglia proliferation and body weight
gain underscores the physiological relevance of our find-
ings to humans, many of whom consume diets rich in
carbohydrates and saturated fats.
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